Christine Ocampo is President & Finance at AVANIR PHARMACEUTICALS, INC. (AVNR). They have made 6 open-market trades across 2 companies since 2009, most recently 2021-03-29.
CIK 0001280154
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $213K since 2009, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NVUS | BUY | 2017-05-10 | 2017-05-11 | $9.99 | $200K | -9.0% | -12.5% | -36.5% |
| AVNR | SELL · 10b5-1 | 2014-12-16 | 2014-12-18 | $16.94 | $606K | N/A | N/A | N/A |
| AVNR | SELL · 10b5-1 | 2014-10-24 | 2014-10-24 | $11.81 | $25K | N/A | N/A | N/A |
| AVNR | SELL · 10b5-1 | 2014-09-15 | 2014-09-17 | $9.45 | $520K | N/A | N/A | N/A |
| AVNR | SELL · 10b5-1 | 2014-08-26 | 2014-08-28 | $6.10 | $13K | N/A | N/A | N/A |
| AVNR | SELL | 2014-05-14 | 2014-05-16 | $5.05 | $189K | N/A | N/A | N/A |
| AVNR | SELL · 10b5-1 | 2013-12-18 | 2013-12-20 | $2.63 | $6K | N/A | N/A | N/A |
| AVNR | SELL · 10b5-1 | 2013-05-15 | 2013-05-17 | $3.28 | $255K | N/A | N/A | N/A |
| AVNR | SELL · 10b5-1 | 2012-12-03 | 2012-12-05 | $2.55 | $7K | N/A | N/A | N/A |
| AVNR | SELL · 10b5-1 | 2012-09-17 | 2012-09-19 | $3.49 | $227K | N/A | N/A | N/A |
| AVNR | BUY | 2012-03-06 | 2012-03-07 | $2.60 | $8K | N/A | N/A | N/A |
| AVNR | SELL · 10b5-1 | 2011-12-02 | 2011-12-06 | $2.38 | $6K | N/A | N/A | N/A |
| AVNR | SELL · 10b5-1 | 2011-11-11 | 2011-11-14 | $2.62 | $242K | N/A | N/A | N/A |
| AVNR | SELL · 10b5-1 | 2010-12-06 | 2010-12-08 | $3.79 | $52K | N/A | N/A | N/A |
| AVNR | SELL | 2010-12-02 | 2010-12-03 | $4.09 | $194K | N/A | N/A | N/A |
| AVNR | SELL | 2010-08-11 | 2010-08-13 | $3.11 | $88K | N/A | N/A | N/A |
| AVNR | SELL · 10b5-1 | 2010-03-16 | 2010-03-17 | $2.08 | $32K | N/A | N/A | N/A |
| AVNR | BUY | 2009-02-24 | 2009-02-25 | $0.44 | $5K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.